Literature DB >> 26694606

Novel Very Long-Chain α-Methoxylated Δ5,9 Fatty Acids from the Sponge Asteropus niger Are Effective Inhibitors of Topoisomerases IB.

Néstor M Carballeira1, Nashbly Montano2, Luis A Amador2, Abimael D Rodríguez2, Mikhail Y Golovko3, Svetlana A Golovko3, Rosa M Reguera4, Raquel Álvarez-Velilla4, Rafael Balaña-Fouce4.   

Abstract

The novel fatty acids (2R,5Z,9Z)-2-methoxy-25-methyl-5,9-hexacosadienoic acid (1a) and (2R,5Z,9Z)-2-methoxy-24-methyl-5,9-hexacosadienoic acid (1b) were isolated in 80 % purity from the Caribbean sponge Asteropus niger by chloroform/methanol extraction followed by solvent partitioning and silica gel column chromatography. The compounds were characterized by utilizing a combination of gas chromatography-mass spectrometry, nuclear magnetic resonance, and circular dichroism. Acids 1a and 1b were not detected in the phospholipids (PtdCho and PtdIns) of the sponge, but rather as free FA and possibly in glycosylceramides. The mixtures of 1a and 1b displayed cytotoxicity towards THP-1 and HepG2 cells with EC50's between 41 and 35 μg/mL. Apoptosis was not the preferred mode of cell death induced by 1a-1b in the THP-1 cells. This implies other types of cytotoxicity mechanisms, such as membrane disruption and/or the inhibition (EC50 = 1.8 μg/mL) of the human topoisomerase IB enzyme (hTopIB), with a mechanism of inhibition different from the one displayed by camptothecin (CPT). In a separate experiment, the mixture of 1a and 1b also displayed cytotoxicity towards ex vivo mouse splenocytes infected with Leishmania infantum amastigotes (IC(50) = 0.17 mg/mL) and free living promastigotes (IC(50) = 0.34 mg/mL). It was also found that the FA were inhibitory of the Leishmania topoisomerase IB (LTopIB) with an EC(50) = 5.1 μg/mL. Taken together, 1a and 1b represent a new class of FA with potential as TopIB inhibitors that preferentially inhibit hTopIB over LTopIB.

Entities:  

Keywords:  Asteropus niger; Cancer; Leishmania infantum; Leishmaniasis; Methoxylated fatty acids; Sponges; Topoisomerase IB

Mesh:

Substances:

Year:  2015        PMID: 26694606      PMCID: PMC4809140          DOI: 10.1007/s11745-015-4114-9

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  22 in total

1.  Conjugated eicosapentaenoic acid inhibits human topoisomerase IB with a mechanism different from camptothecin.

Authors:  Silvia Castelli; Alessia Campagna; Oscar Vassallo; Cinzia Tesauro; Paola Fiorani; Pietro Tagliatesta; Francesco Oteri; Mattia Falconi; Hemanta K Majumder; Alessandro Desideri
Journal:  Arch Biochem Biophys       Date:  2009-05-04       Impact factor: 4.013

2.  Studies on the lipid composition of developing soybeans.

Authors:  O S Privett; K A Dougherty; W L Erdahl; A Stolyhwo
Journal:  J Am Oil Chem Soc       Date:  1973-12       Impact factor: 1.849

Review 3.  High resolution 13C NMR. A technique for the study of lipid structure and composition.

Authors:  F D Gunstone
Journal:  Prog Lipid Res       Date:  1994       Impact factor: 16.195

Review 4.  Targeting atypical trypanosomatid DNA topoisomerase I.

Authors:  Rafael Balaña-Fouce; Carmen M Redondo; Yolanda Pérez-Pertejo; Rosario Díaz-González; Rosa M Reguera
Journal:  Drug Discov Today       Date:  2006-08       Impact factor: 7.851

5.  Stereoselective synthesis of 11-phenylundeca-5Z,9Z-dienoic acid and investigation of its human topoisomerase I and IIα inhibitory activity.

Authors:  Vladimir A D'yakonov; Lilya U Dzhemileva; Aleksey A Makarov; Alfiya R Mulukova; Dmitry S Baev; Elza K Khusnutdinova; Tatiana G Tolstikova; Usein M Dzhemilev
Journal:  Bioorg Med Chem Lett       Date:  2015-04-10       Impact factor: 2.823

6.  Identification of the new 23-methyl-5,9-pentacosadienoic acid in the sponge Cribrochalina vasculum.

Authors:  N M Carballeria; E D Reyes
Journal:  Lipids       Date:  1990-01       Impact factor: 1.880

7.  Glycolipids from sponges. 13. Clarhamnoside, the first rhamnosylated alpha-galactosylceramide from Agelas clathrodes. Improving spectral strategies for glycoconjugate structure determination.

Authors:  Valeria Costantino; Ernesto Fattorusso; Concetta Imperatore; Alfonso Mangoni
Journal:  J Org Chem       Date:  2004-02-20       Impact factor: 4.354

8.  First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the leishmania topoisomerase IB enzyme.

Authors:  Néstor M Carballeira; Michelle Cartagena; Fengyu Li; Zhongfang Chen; Christopher F Prada; Estefania Calvo-Alvarez; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Pure Appl Chem       Date:  2012-04-29       Impact factor: 2.453

Review 9.  Membrane-perturbing effect of fatty acids and lysolipids.

Authors:  Ahmad Arouri; Ole G Mouritsen
Journal:  Prog Lipid Res       Date:  2012-10-29       Impact factor: 16.195

10.  Synthesis of marine α-methoxylated fatty acid analogs that effectively inhibit the topoisomerase IB from Leishmania donovani with a mechanism different from that of camptothecin.

Authors:  Néstor M Carballeira; Nashbly Montano; Raquel Alvarez-Velilla; Christopher F Prada; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Mar Drugs       Date:  2013-09-30       Impact factor: 5.118

View more
  6 in total

1.  (4Z,15Z)-Octadecadienoic Acid Inhibits Glycogen Synthase Kinase-3β and Glucose Production in H4IIE Cells.

Authors:  Jun Yoshida; Shota Uesugi; Tetsuaki Kawamura; Ken-Ichi Kimura; Dawei Hu; Shuang Xia; Naoki Toyooka; Masao Ohnishi; Hideki Kawashima
Journal:  Lipids       Date:  2017-02-13       Impact factor: 1.880

2.  2-Methoxylated FA Display Unusual Antibacterial Activity Towards Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (CIMRSA) and Escherichia coli.

Authors:  Néstor M Carballeira; Nashbly Montano; Christian Morales; Joseph Mooney; Xiomara Torres; Dakeishla Díaz; David J Sanabria-Rios
Journal:  Lipids       Date:  2017-05-18       Impact factor: 1.880

3.  Novel Odd-Chain Fatty Acids with a Terminal Double Bond in Ovaries of the Limpet Cellana toreuma.

Authors:  Hideki Kawashima; Masao Ohnishi
Journal:  Lipids       Date:  2017-02-23       Impact factor: 1.880

Review 4.  Biomaterials and Bioactive Natural Products from Marine Invertebrates: From Basic Research to Innovative Applications.

Authors:  Giovanna Romano; Mariana Almeida; Ana Varela Coelho; Adele Cutignano; Luis G Gonçalves; Espen Hansen; Denis Khnykin; Tali Mass; Andreja Ramšak; Miguel S Rocha; Tiago H Silva; Michela Sugni; Loriano Ballarin; Anne-Marie Genevière
Journal:  Mar Drugs       Date:  2022-03-22       Impact factor: 6.085

Review 5.  Marine Pharmacology in 2016-2017: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2021-01-21       Impact factor: 5.118

Review 6.  Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.

Authors:  María Álvarez-Bardón; Yolanda Pérez-Pertejo; César Ordóñez; Daniel Sepúlveda-Crespo; Nestor M Carballeira; Babu L Tekwani; Sankaranarayanan Murugesan; Maria Martinez-Valladares; Carlos García-Estrada; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Mar Drugs       Date:  2020-03-31       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.